首页> 外文OA文献 >Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates
【2h】

Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates

机译:与实际腺瘤检出率比较,开发和验证筛查和监测结肠镜检查中腺瘤检出预测模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: The adenoma detection rate (ADR) varies widely between physicians, possibly due to patient population differences, hampering direct ADR comparison. We developed and validated a prediction model for adenoma detection in an effort to determine if physicians' ADRs should be adjusted for patient-related factors. MATERIALS AND METHODS: Screening and surveillance colonoscopy data from the cross-sectional multicenter cluster-randomized Endoscopic Quality Improvement Program-3 (EQUIP-3) study (NCT02325635) was used. The dataset was split into two cohorts based on center. A prediction model for detection of >/=1 adenoma was developed using multivariable logistic regression and subsequently internally (bootstrap resampling) and geographically validated. We compared predicted to observed ADRs. RESULTS: The derivation (5 centers, 35 physicians, overall-ADR: 36%) and validation (4 centers, 31 physicians, overall-ADR: 40%) cohort included respectively 9934 and 10034 patients (both cohorts: 48% male, median age 60 years). Independent predictors for detection of >/=1 adenoma were: age (optimism-corrected odds ratio (OR): 1.02; 95%-confidence interval (CI): 1.02-1.03), male sex (OR: 1.73; 95%-CI: 1.60-1.88), body mass index (OR: 1.02; 95%-CI: 1.01-1.03), American Society of Anesthesiology physical status class (OR class II vs. I: 1.29; 95%-CI: 1.17-1.43, OR class >/=III vs. I: 1.57; 95%-CI: 1.32-1.86), surveillance versus screening (OR: 1.39; 95%-CI: 1.27-1.53), and Hispanic or Latino ethnicity (OR: 1.13; 95%-CI: 1.00-1.27). The model's discriminative ability was modest (C-statistic in the derivation: 0.63 and validation cohort: 0.60). The observed ADR was considerably lower than predicted for 12/66 (18.2%) physicians and 2/9 (22.2%) centers, and considerably higher than predicted for 18/66 (27.3%) physicians and 4/9 (44.4%) centers. CONCLUSION: The substantial variation in ADRs could only partially be explained by patient-related factors. These data suggest that ADR variation could likely also be due to other factors, e.g. physician or technical issues.
机译:目的:医生之间的腺瘤检出率(ADR)可能存在很大差异,这可能是由于患者人群的差异所致,从而妨碍了ADR的直接比较。我们开发并验证了腺瘤检测的预测模型,以确定是否应针对患者相关因素调整医生的ADR。材料与方法:采用跨部门多中心集群随机内镜质量改善计划3(EQUIP-3)研究(NCT02325635)的筛查和监测结肠镜检查数据。根据中心将数据集分为两个队列。使用多变量logistic回归开发了用于检测> / = 1腺瘤的预测模型,随后进行了内部(自举重采样)并进行了地理验证。我们将预测的ADR与观察到的ADR进行了比较。结果:派生(5个中心,35位医生,整体ADR:36%)和验证(4个中心,31位医生,整体ADR:40%)队列分别包括9934和10034例患者(两组:男性48%,中位数年龄60岁)。检测> / = 1腺瘤的独立预测因子为:年龄(乐观校正后的优势比(OR):1.02; 95%置信区间(CI):1.02-1.03);男性(OR:1.73; 95%-CI :1.60-1.88),体重指数(OR:1.02; 95%-CI:1.01-1.03),美国麻醉学会物理状态等级(OR等级II对I:1.29; 95%-CI:1.17-1.43,类别> / = III与I:1.57; 95%-CI:1.32-1.86),监视与筛查(OR:1.39; 95%-CI:1.27-1.53​​)以及西班牙裔或拉丁裔(OR:1.13; 95%-CI:1.00-1.27)。该模型的判别能力适中(推导中的C统计量:0.63,验证队列:0.60)。观察到的ADR大大低于12/66(18.2%)医生和2/9(22.2%)中心的预期,并且远高于18/66(27.3%)医生和4/9(44.4%)中心的预期。结论:ADR的实质性变化只能部分由患者相关因素来解释。这些数据表明ADR的变化也可能是由于其他因素造成的,例如医生或技术问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号